LYNNETTE K. NIEMAN, M.D.; GEORGE P. CHROUSOS, M.D.; EDWARD H. OLDFIELD, M.D.; PETER C. AVGERINOS, M.D.; GORDON B. CUTLER, M.D.; D. LYNN LORIAUX, M.D., Ph.D.
NIEMAN LK, CHROUSOS GP, OLDFIELD EH, AVGERINOS PC, CUTLER GB, LORIAUX DL. The Ovine Corticotropin-Releasing Hormone Stimulation Test and the Dexamethasone Suppression Test in the Differential Diagnosis of Cushing's Syndrome. Ann Intern Med. 1986;105:862-867. doi: 10.7326/0003-4819-105-6-862
Download citation file:
Published: Ann Intern Med. 1986;105(6):862-867.
We gave a standard dexamethasone suppression test and an ovine corticotropin-releasing hormone (CRH) stimulation test to 41 patients with adrenocorticotrophic hormone (ACTH)-dependent hypercortisolism to determine the efficacy of each test in the differential diagnosis of Cushing's syndrome. Twenty-nine of thirty-three patients with Cushing's disease and 0 of 8 patients with ectopic secretion of ACTH responded to the ovine CRH test with increased levels of cortisol. When a cortisol response was judged as positive for Cushing's disease, the CRH test had a diagnostic sensitivity, specificity, and accuracy of 88%, 100%, and 90%, respectively. Twenty-nine patients with Cushing's disease and 1 patient with ectopic secretion of ACTH responded to the dexamethasone suppression test. A combined-test strategy requiring negative results from both tests to exclude a diagnosis of Cushing's disease yielded superior sensitivity (100%) and diagnostic accuracy (98%). Thus, the ovine CRH test works as well as the standard dexamethasone suppression test in discriminating between Cushing's disease and ectopic ACTH secretion. The diagnostic power of each test is enhanced when the two tests are combined.
Learn more about subscription options.
Register Now for a free account.
Endocrine and Metabolism, Adrenal Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only